Role of parametric resonance in virological failure during HIV treatment interruption therapy (Q46757553)

24 December 2017

title

Role of parametric resonance in virological failure during HIV treatment interruption therapy (English)

1 reference

24 December 2017

0 references

2

Sally Blower

1 reference

24 December 2017

author name string

Romulus Breban

series ordinal

1

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

24 December 2017

number of pages

5

1 reference

inferred from page(s)

published in

The Lancet

1 reference

24 December 2017

volume

367

1 reference

24 December 2017

issue

9518

1 reference

24 December 2017

page(s)

1285-1289

1 reference

24 December 2017

Less is more? STI in acute and chronic HIV-1 infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Randomized, controlled trial of therapy interruption in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Structured treatment interruptions to control HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Clinical trials of zidovudine in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Dynamical resonance can account for seasonality of influenza epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Population dynamics of immune responses to persistent viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Viral dynamics in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Modelling viral and immune system dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

T cell dynamics in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

In vivo estimates of division and death rates of human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968543-7

7 January 2021

10.1016/S0140-6736(06)68543-7

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017